Skip to content

Clinical trials

Completed Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Status: Completed Country / region: Austria Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20054
20061
20072
20091
20101
20121
20134
20181
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Bristol-Myers Squibb5
Arbeitsgemeinschaft medikamentoese Tumortherapie1
Gruppo Italiano Malattie EMatologiche dell'Adulto1
Medical University of Graz1
Pfizer1
St. Anna Kinderkrebsforschung1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive18
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Leukemia3
Leukemia, Myeloid2
Blast Crisis1
Bone Marrow Diseases1
Gastrointestinal Stromal Tumors1
Hematologic Diseases1
Hematologic Neoplasms1
Hypereosinophilic Syndrome1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.